Greenberg Traurig LLP boasts ‘very deep expertise’ in life sciences mandates, with particular expertise in overseeing IP-heavy transactions, where the practice helps clients shape their patent strategies and develop their portfolios, covering novel products in the pharmaceutical, medical devices and biotech markets. The practice is overseen by Boston-based David Dykeman, a specialist in securing patents for clients’ new products and in the strategic management of their portfolios, and Atlanta’s Wayne Elowe, who oversees transactions including M&A and licensing deals, in addition to assisting with specific asset purchases. Melissa Hunter-Ensor, also based in Boston, maintains a broad patent practice that encompasses both portfolio management and litigation.
Testimonials
Collated independently by Legal 500 research team.
- 'Our GT team has very deep expertise, not just in life sciences but in the specific area we work in.'
- 'The Greenberg Traurig team provides excellent patent prosecution services in all areas of the life sciences to my institution. They fully understand our business and its complex needs, and I can always be sure that someone from GT will fully grasp any invention disclosed to them.'
Key clients
- Moderna, Inc.
- Provention Bio, Inc.
- Huadong Medicine Co.
- Teva Pharmaceuticals
- AnnJi Pharmaceutical
- Aspira Women’s Health
- Embecta Corp.
- Exactech, Inc.
- Elios Vision
- Redhill Biopharma
Work highlights
- Represented Moderna, Inc. in defending its COVID-19 vaccine against patent infringement claims brought by Promosome.
- Assisted Provention Bio, Inc. with the IP aspects of two public stock offerings and a private placement.
- Represented Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. in the global expansion of the strategic alliance for SCO-094, a GLP-1R and GIPR dual agonist with SCOHIA PHARMA, Inc.
Practice head
The lawyer(s) leading their teams.
David Dykeman, Wayne Elowe